Brief: Lyell Immunopharma Q1 Net Income USD -24.153 Million
06/05/2026 21:05
May 06 (Reuters) - Lyell Immunopharma Q1 revenue USD 2 thousand vs. IBES estimate USD 4.4 thousand. Q1 operating expenses USD 44.263 million Q1 operating income USD -44.261 million Q1 adjusted net income USD 37.8 million vs. IBES estimate USD -53.2 million
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma